Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors

Due to organ shortage, donation after circulatory death (DCD) has increased. As DCD kidney grafts have higher rates of delayed graft function (DGF), the French national protocol mandates the use of hypothermic machine perfusion and routine anti-thymocyte globulin (ATG) induction therapy. However, ev...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Martin Deslais, Alice Koenig, Fanny Buron, Gabriel Ouellet, Maud Rabeyrin, Cécile Picard, Frédérique Dijoud, Renaud Snanoudj, Mohamad Zaidan, Florent von Tokarski, Arwa Jalal Eddine, Moglie Le Quintrec, Jean-Emmanuel Serre, Alice Corbel, Adrien Flahault, Magali Giral, Christophe Masset, Dany Anglicheau, Olivier Aubert, Antoine Sicard, Clément Gosset, Carmen Lefaucheur, Gillian Divard, Christophe Mariat, Quentin Monchal, Xavier Matillon, Anne-Claire Lukaszewicz, Valérie Dubois, Emmanuel Morelon, Olivier Thaunat, Xavier Charmetant
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2026-06-01
Цуврал:	Transplant International
Нөхцлүүд:	antithymocyte globulin basiliximab DCD (donation after circulatory death) delayed graft function induction
Онлайн хандалт:	https://www.frontierspartnerships.org/articles/10.3389/ti.2026.15318/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!